Skip to main content

CBD industry craves regulation in united states

Brian baum, president and leader executive officer of cannovia, which makes and markets cbd-infused merchandise inclusive of pure cbd oil, chewing gum, and lotions, informed healthline that a loss of labeling requirements is particularly puzzling for purchasers.

“quite a few products available on the market don’t have a therapeutic dose” — which baum defined as 500 to one thousand milligrams (mg) of cbd — “so labeling requirements will play an critical function,” he said.

“the enterprise could be very interested by some kind of sensible regulation to usher in a few requirements and shield customers and manufacturers,” said baum.

Comments